Complexity of the microglial activation pathways that drive innate host responses during lethal alphavirus encephalitis in mice

ASN Neuro

Volumn 4, Issue 4, 2012, Pages 207-221

  Esen, Nilufer ^a   Blakely, Pennelope K ^a   Rainey Barger, Emily K ^a   Irani, David N ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Encephalitis; Microglia; Sindbis virus; Toll like receptors; Type i interferon; UNC93b1

Indexed keywords

ALPHA INTERFERON; CD11B ANTIGEN; CHAPERONE; CXCL13 CHEMOKINE; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 12P40; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; RANTES; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNC93B1 PROTEIN; UNCLASSIFIED DRUG;

ALPHA VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; INNATE IMMUNITY; MICROGLIA; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; SINDBIS VIRUS; VIRUS ENCEPHALITIS; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS UNCOATING;

ALPHAVIRUS INFECTIONS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD11B; CELLS, CULTURED; CEREBRAL CORTEX; CYTOKINES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENCEPHALITIS, VIRAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MONOCYTES; MUTATION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 84862670894     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1042/AN20120016     Document Type: Article

References (68)

1. Akira S, Takeda K (2004) Toll-like receptor signaling. Nat Rev Immunol 4:499-511.
2. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801.
3. Aloisi F, Columba-Cabezas S, Franciotta D, Rosicarelli B, Magliozzi R, Reynolds R, Ambrosini E, Salvetti M, Serafini B (2008) Lymphoidchemokines in chronic neuroinflammation. J Neuroimmunol 198:106-112.
4. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster JD, Sedgwick JD, Browning JL, Lipp M, Cyster JG (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406:309-314.
5. Bagaeva LV, Rao P, Powers JM, Segal BM (2006) CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J Immunol 176:7676-7685.
6. Barbalat R, Lau L, Locksley RM, Barton GM (2009) Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 10:1200-1207.
7. Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh H, Kim YM (2007) The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 177:265-275.
8. Byrnes AP, Durbin JE, Griffin DE (2000) Control of Sindbis virus replication by antibody in interferon-deficient mice. J Virol 74:3905-3908.
9. Carlson T, Kroenke M, Rao P, Lane TE, Segal B (2008) The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J Exp Med 205:811-823.
10. Carmen J, Rothstein JD, Kerr DA (2009) Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis. Brain Res 1263:143-154.
11. Casrouge A, Zhang S-Y, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, Lorenzo L, Plancoulaine S, Senechal B, Geissmann F, Tabeta K, de Villemeur TB, Lebon P, Dulac O, Rozenberg F, Beutler B, Tardieu M, Abel L, Casanova J-L (2006) Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308-312.
12. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE (2008) Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 83:64-70.
13. Darman J, Backovic S, Dike S, Maragakis NJ, Krishnan C, Rothstein JD, Irani DN, Kerr DA (2004) Viral-induced spinal motor neuron death is non-cellautonomous and involves glutamate excitotoxicity. J Neurosci 24:7566-7575.
14. Depres P, Griffin JW, Griffin DE (1996) Antiviral activity of alpha interferon in Sindbis virus-infected cells is restored by anti-E2 monoclonal antibody treatment. J Virol 69:7345-7348.
15. Drose S, Altendorf K (1997) Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J Exp Biol 200:1-8.
16. Esen N, Kielian T (2005) Recognition of Staphylococcus aureus-derived peptidoglycan but not intact bacteria is mediated by CD14 in microglia. J Neuroimmunol 170:93-104.
17. Forster R, Matis AE, Kremmer E, Wolf E, Brem G, Lipp M (1996) A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-1047.
18. Genin P, Vaccaro A, Civas A (2009) The role of differential expression of human interferon-A genes in antiviral immunity. Cytokine Growth Factor Rev 20:283-295.
19. Grieder FB, Vogel SN (1999) Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Virology 257:106-118.
20. Havert MB, Scholfield B, Griffin DE, Irani DN (2000) Activation of divergent neuronal cell death pathways in different target cell populations during neuroadapted Sindbis virus infection of mice. J Virol 74:5352-5356.
21. Huang SY, Hertzog PJ, Holland KA, Sumarsono SH, Tymms MJ, Hamilton JA, Whitty G, Bertoncello I, Kola I (1995) A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc Natl Acad Sci USA 92:11284-11288.
22. Irani DN, Griffin DE (1990) Isolation of brain parenchymal lymphocytes for flow cytometric analysis. Application to acute viral encephalitis. J Immunol Meth 139:223-231.
23. Irani DN, Prow NA (2007) Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis. J Neuropathol Exp Neurol 66:533-544.
24. Jan J-T, Griffin DE (1999) Induction of apoptosis by Sindbis virus occurs at cell entry and does not require virus replication. J Virol 73:10296-10302.
25. Janeway C, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216.
26. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh C-S, Reise Sousa C, Matsuura Y, Fujita T, Akira S (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
27. Kerr DA, Larsen T, Cook SH, Fannjiang YR, Choi E, Griffin DE, Hardwick JM, Irani DN (2002) Bcl-2 and Bax protect adult mice from lethal Sindbis virus infection but do not protect spinal cord motor neurons or prevent paralysis. J Virol 76:10393-10400.
28. Khademi M, Kockum I, Andersson ML, Iacobaeus E, Brundin L, Sellebjerg F, Hillert J, Piehl F, Olsson T (2011) Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. Mult Scler 17:335-343.
29. Kim YM, Brinkmann MM, Paquet ME, Ploegh HL (2008) UNC93B1 delivers nucleotide-sensing Toll-like receptors to endolysosomes. Nature 452:234-238.
30. King IL, Dickendesher TL, Segal BM (2009) Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113:3190-3197.
31. Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, Newcombe J, Hohlfeld R, Meinl E (2006) Chemokines in multiple sclerosis: CXCR12 and CXCR13 upregulation is differentially linked to CNS immune cell recruitment. Brain 129:200-211.
32. Lalor SJ, Segal BM (2010) Lymphoid chemokines in the CNS. J Neuroimmunol 224:56-61.
33. Legler DF, Loetscher M, Roos R, Clark-Lewis I, Baggiolini M, Moser B (1998) B-cell attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 187:655-660.
34. Lewis J, Wesselingh SL, Griffin DE, Hardwick JM (1996) Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J Virol 70:1828-1835.
35. Magliozzi R, Columba-Cabezas S, Serafini B, Aloisi F (2004) Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 148:11-23.
36. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Popolo M, Reynolds R, Aloisi F (2007) Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130:1089-1104.
37. Melo MB, Kasperkovitz P, Cerny A, Konen-Waisman S, Kurt-Jones EA, Lein E, Beutler B, Howard JC, Golenbock DT, Gazzinelli RT (2010) UNC93B1 mediates host resistance to infection with Toxoplasma gondii. PLoS Pathog 6:e1001071
38. Moench TR, Griffin DE (1984) Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges, and brain during acute viral meningoencephalitis. J Exp Med 159:77-88.
39. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M (1994) Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
40. Nargi-Aizenman JL, Havert MB, Zhang M, Irani DN, Rothstein JD, Griffin DE (2004) Glutamate receptor antagonists protect from virus-induced neural degeneration. Ann Neurol 55:541-549.
41. Ning S, Pagano JS, Barber GN (2011) IRF7: activation, regulation, modification and function. Genes Immun 12:399-414.
42. Olson JK, Miller SD (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916-3924.
43. Piccio L, Naismith RT, Trinkaus K, Klein RS, Parks BJ, Lyons JA, Cross AH (2010) Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Arch Neurol 67:707-714.
44. Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis Study Group (1998) Randomized double-blind placebo-controlled study of interferon beta-1a in relapsing-remitting multiple sclerosis. Lancet 352:1498-1504.
45. Prow NA, Irani DN (2007) The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis. Exp Neurol 205:461-470.
46. Prow NA, Irani DN (2008) The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis. J Neurochem 105:1276-1286.
47. Ragheb S, Li Y, Simon K, Vanhaerents S, Galimberti D, De Riz M, Fenoglio C, Scarpini E, Lisak R (2011) Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid. Mult Scler 17:819-829.
48. Ryman KD, Klimstra WB, Nguyen KB, Biron CA, Johnston RE (2000) Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol 74:3366-3378.
49. Saitoh S-I, Miyake K (2009) Regulatory molecules required for nucleotidesensing Toll-like receptors. Immunol Rev 227:32-43.
50. Sellebjerg F, Bornsen L, Khademi M, Krakauer M, Olsson T, Frederiksen JL, Sorensen PS (2009) Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology 73:2003-2010.
51. Serafini B, Rosicarelli B, Magiozzi R, Aloisi F (2004) Detection of ectopic B-cell follicles with germinal centers in meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14:164-174.
52. Sherman LA, Griffin DE (1990) Pathogenesis of encephalitis induced in newborn mice by virulent and avirulent strains of Sindbis virus. J Virol 64:2041-2046.
53. Shi Z, Cai Z, Sanchez A, Zhang T, Wen S, Wang J, Yang J, Fu S, Zhang D (2011) A novel Toll-like receptor that recognizes vesicular stomatitis virus. J Biol Chem 286:4517-4524.
54. Strauss JH, Strauss EG (1994) The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 58:491-562.
55. Tabeta K, Hoebe K, Janssen EM, Du X, Georgel P, Crozat K, Mudd S, Mann N, Sovath S, Goode J, Shamel L, Herskovits AA, Portnoy DA, Cooke M, Tarantino LM, Wiltshire T, Steinberg BE, Grinstein S, Beutler B (2006) The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 7:156-164.
56. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335-376.
57. The IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655-661.
58. The Multiple Sclerosis Collaborative Research Group (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 39:285-294.
59. The Multiple Sclerosis Collaborative Research Group (1998) Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. Ann Neurol 43:79-87.
60. UBC MS/MRI Study Group and The IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, doubleblind, placebo-controlled trial. Neurology 43:662-667.
61. Vilcek J (1964) Production of interferon by newborn and adult mice infected with Sindbis virus. Virology 22:651-652.
62. Wang JP, Bowen GN, Zhou S, Cerny A, Zacharia A, Knipe DM, Finberg RW, Kurt-Jones EA (2011) Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J Virol 86: 2273-2281.
63. Wesselingh SL, Levine B, Fox RJ, Choi S, Griffin DE (1994) Intracerebral cytokinemRNA expression during fatal and nonfatal alphavirus encephalitissuggests a predominant type 2 T cell response. J Immunol 152:1289-1297.
64. Zhang S-Y, Jouanguy E, Sancho-Shimizu V, von Bernuth H, Yang K, Abel L, Picard C, Puel A, Casanova J-L (2007) Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol Rev 220:225-236.
65. Vilcek J (1964) Production of interferon by newborn and adult mice infected with Sindbis virus. Virology 22:651-652.
66. Wang JP, Bowen GN, Zhou S, Cerny A, Zacharia A, Knipe DM, Finberg RW, Kurt-Jones EA (2011) Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J Virol 86: 2273-2281.
67. Wesselingh SL, Levine B, Fox RJ, Choi S, Griffin DE (1994) Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitissuggests a predominant type 2 T cell response. J Immunol 152:1289-1297.
68. Zhang S-Y, Jouanguy E, Sancho-Shimizu V, von Bernuth H, Yang K, Abel L, Picard C, Puel A, Casanova J-L (2007) Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol Rev 220:225-236.